Found 108 matching trials
Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding PHASE3 This trial is conducted globally. The purpose of the trial is to evaluate t...
Show More Location
Novo Nordisk Clinical Trial Call Center
Learn More & Join Trial
Safety and Tolerability of Intravenous Doses of Activated Recombinant Human Factor VII in Healthy Volunteers PHASE1 This trial is conducted in Europe. The aim of this trial is to investigate ...
Show More Location
Novo Nordisk Investigational Site
Learn More & Join Trial
A Study to Test a Medicine (Fitusiran) Injected Under the Skin for Preventing Bleeding Episodes in Male Adolescent or Adult Participants With Severe Hemophilia PHASE3 This is a multicenter, multinational, open-label, one-way cross-over, Phase...
Show More Status
Active Not Recruiting
Location
Center for Inherited Blood Disorders (CIBD) Site Number : 8400012
Learn More & Join Trial
Observational Study on the Efficacy and Safety of NovoSeven® During "Real-life" Usage in Germany N/A This NON INTERVENTIONAL OBSERVATIONAL STUDY is conducted in Europe. The pri...
Show More Location
Novo Nordisk Investigational Site
Learn More & Join Trial
Comparative Outcomes of PCC and Recombinant Activated Factor VIIa in Trauma-Associated Massive Transfusion N/A This study aims to compare the incidence of thromboembolic complications am...
Show More Location
UF Health Jacksonville (Shands Hospital)
Learn More & Join Trial
Observational Study on Safety of Room Temperature Stable NovoSeven® in Patients With Haemophilia A or B N/A This study is conducted in Europe and Asia. The aim of this observational s...
Show More Location
Multiple Locations
Learn More & Join Trial
Factor IX as Adjunctive Therapy to Emicizumab (EMIX) EARLY_PHASE1 This trial will enroll patients with severe hemophilia A. Experiments will ...
Show More Location
Tulane University Lakeside Hospital and Clinics
Learn More & Join Trial
A Single-dose, Dose-escalation Study of a Long-acting MOD-5014 in Healthy Adult Male PHASE1 A Phase 1, randomized, single-blind, placebo-controlled, single dose, dose-...
Show More Learn More & Join Trial
Efficacy and Safety of Activated Recombinant Human Factor VII in Treatment of Bleeding in Patients Following Hematopoietic Stem Cell Transplantation PHASE2 This trial is conducted in the United States of America (USA). The aim of t...
Show More Location
Novo Nordisk Investigational Site
Learn More & Join Trial
Efficacy and Safety of Activated Recombinant Human Factor VII in Severely Injured Trauma Patients PHASE2 This trial is conducted in Africa, Asia, Europe, Oceania and North America....
Show More Location
Novo Nordisk Investigational Site
Learn More & Join Trial